Problem of 30-Day Readmission for Heart Failure Could Be Improved. Results of IMPEDANCE-HF Extended Trial

Journal of Cardiac Failure - United States
doi 10.1016/j.cardfail.2019.07.415
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Residual Congestion on Discharge for Heart Failure Assessed by Impedance Technique Predicts 30-Day and One-Year Heart Failure Death. Results of IMPEDANCE-HF Extended Trial

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Improved 30 Day Readmission Rates Following Institution of Heart Failure Treatment Algorithms

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2018English

Polypharmacy Increases Heart Failure (HF) Readmission Rate

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

B-Type Natriuretic Peptide Predicts 30-Day Readmission for Heart Failure but Not Readmission for Other Causes

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2014English

The Relationship Between Nurse Staffing and 30-Day Readmission for Adults With Heart Failure

Journal of Nursing Administration
MedicineLeadershipManagement
2016English

Discharge Readiness Assessment and 30-Day Readmission Risk in Acute Decompensated Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2017English

Atrial Fibrillation Increases Risk for 30-Day Hospital Readmission in Heart Failure With Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients With Congestive Heart Failure

American Journal of Medicine
Medicine
2016English

Impact of a Pharmacist-Led Intervention on 30-Day Readmission and Assessment of Factors Predictive of Readmission in African American Men With Heart Failure

American Journal of Men's Health
EnvironmentalPublic HealthHealthOccupational Health
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy